Lipocine Inc.

NASDAQ: LPCN · Real-Time Price · USD
3.03
-0.01 (-0.33%)
At close: Aug 15, 2025, 3:59 PM
3.04
0.33%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lipocine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8.35K -16.35M -10.76M -634.4K
Depreciation & Amortization
41.11K 28.66K 9.45K 380.00
Stock-Based Compensation
408.55K 654.44K 636.14K 603.95K
Other Working Capital
228.26K 473.83K -234.68K -4.29M
Other Non-Cash Items
-715.03K 1.8M -932.15K 53.75K
Deferred Income Tax
n/a n/a n/a 159.69K
Change in Working Capital
-964.21K 2.01M -923.63K -4.59M
Operating Cash Flow
-1.22M -11.87M -11.97M -4.41M
Capital Expenditures
-90.09K -13.17K -133.83K -7.59K
Cash Acquisitions
n/a n/a -14.29M 43.78B
Purchase of Investments
-32.86M -22.9M -45.07M -48.42M
Sales Maturities Of Investments
35.4M 36M 59.5M 4.65M
Other Investing Acitivies
n/a n/a 14.29M -43.78B
Investing Cash Flow
2.45M 13.08M 14.29M -43.78M
Debt Repayment
n/a n/a -2.32M -3.33M
Common Stock Repurchased
n/a n/a -21.7K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -21.7K 11.69K
Financial Cash Flow
209.34K 404.57K -2.13M 26.92M
Net Cash Flow
1.43M 1.62M 197.94K -21.27M
Free Cash Flow
-1.31M -11.88M -12.1M -4.42M